310 related articles for article (PubMed ID: 15198182)
1. Neisseria meningitidis W-135 carriage during the Hajj season 2003.
Balkhy HH; Memish ZA; Almuneef MA; Osoba AO
Scand J Infect Dis; 2004; 36(4):264-8. PubMed ID: 15198182
[TBL] [Abstract][Full Text] [Related]
2. Meningococcal carriage in Umra pilgrims returning from Saudi Arabia.
Wilder-Smith A; Paton NI; Barkham TM; Earnest A
J Travel Med; 2003; 10(3):147-9. PubMed ID: 12757687
[TBL] [Abstract][Full Text] [Related]
3. Neisseria meningitidis nasopharyngeal carriage during the Hajj: A cohort study evaluating the need for ciprofloxacin prophylaxis.
Memish ZA; Al-Tawfiq JA; Almasri M; Azhar EI; Yasir M; Al-Saeed MS; Ben Helaby H; Borrow R; Turkistani A; Assiri A
Vaccine; 2017 Apr; 35(18):2473-2478. PubMed ID: 28343777
[TBL] [Abstract][Full Text] [Related]
4. Neisseria meningitidis serogroup W-135 carriage among US travelers to the 2001 Hajj.
Dull PM; Abdelwahab J; Sacchi CT; Becker M; Noble CA; Barnett GA; Kaiser RM; Mayer LW; Whitney AM; Schmink S; Ajello GW; Dolan-Livengood J; Stephens DS; Cetron MS; Popovic T; Rosenstein NE
J Infect Dis; 2005 Jan; 191(1):33-9. PubMed ID: 15593000
[TBL] [Abstract][Full Text] [Related]
5. Meningococcal carriage among Hajj pilgrims, risk factors for carriage and records of vaccination: a study of pilgrims to Mecca.
Alasmari A; Houghton J; Greenwood B; Heymann D; Edwards P; Larson H; Assiri A; Ben-Rached F; Pain A; Behrens R; Bustinduy A
Trop Med Int Health; 2021 Apr; 26(4):453-461. PubMed ID: 33415766
[TBL] [Abstract][Full Text] [Related]
6. Acquisition of meningococcal serogroup W-135 carriage in Turkish Hajj pilgrims who had received the quadrivalent meningococcal polysaccharide vaccine.
Ceyhan M; Celik M; Demir ET; Gurbuz V; Aycan AE; Unal S
Clin Vaccine Immunol; 2013 Jan; 20(1):66-8. PubMed ID: 23136117
[TBL] [Abstract][Full Text] [Related]
7. The impact of meningococcal conjugate vaccine (MenACWY-TT) on meningococcal carriage in Hajj Pilgrims returning to Turkey.
Tezer H; Gülhan B; Simge Gişi A; Nar Ötgün S; Kanık-Yüksek S; Özkaya-Parlakay A; Kılıç S; Ünal Şahin N; Şimşek AÇ; Kara A
Hum Vaccin Immunother; 2020 Jun; 16(6):1268-1271. PubMed ID: 31674862
[TBL] [Abstract][Full Text] [Related]
8. Absence of Neisseria meningitidis W-135 electrophoretic Type 37 during the Hajj, 2002.
Wilder-Smith A; Barkham TM; Chew SK; Paton NI
Emerg Infect Dis; 2003 Jun; 9(6):734-7. PubMed ID: 12781018
[TBL] [Abstract][Full Text] [Related]
9. Laboratory-confirmed invasive meningococcal disease: effect of the Hajj vaccination policy, Saudi Arabia, 1995 to 2011.
Memish Z; Al Hakeem R; Al Neel O; Danis K; Jasir A; Eibach D
Euro Surveill; 2013 Sep; 18(37):. PubMed ID: 24079399
[TBL] [Abstract][Full Text] [Related]
10. Consensus recommendation for meningococcal disease prevention for Hajj and Umra pilgrimage/travel medicine.
Shibl A; Tufenkeji H; Khalil M; Memish Z;
East Mediterr Health J; 2013 Apr; 19(4):389-92. PubMed ID: 23882966
[TBL] [Abstract][Full Text] [Related]
11. Meningococcal carriage among local inhabitants during the pilgrimage 2000-2001.
Balkhy HH; Memish ZA; Osoba AO
Int J Antimicrob Agents; 2003 Feb; 21(2):107-11. PubMed ID: 12615372
[TBL] [Abstract][Full Text] [Related]
12. Meningococcal disease and prevention at the Hajj.
Borrow R
Travel Med Infect Dis; 2009 Jul; 7(4):219-25. PubMed ID: 19717104
[TBL] [Abstract][Full Text] [Related]
13. Serogroup B meningococcal disease during Hajj: preparing for the worst scenario.
Khalil MK; Borrow R
Travel Med Infect Dis; 2009 Jul; 7(4):231-4. PubMed ID: 19717106
[TBL] [Abstract][Full Text] [Related]
14. W135 meningococcal carriage in association with the Hajj pilgrimage 2001: the Singapore experience.
Wilder-Smith A
Int J Antimicrob Agents; 2003 Feb; 21(2):112-5. PubMed ID: 12615373
[TBL] [Abstract][Full Text] [Related]
15. Prevalence and epidemiology of meningococcal carriage in Southern Ethiopia prior to implementation of MenAfriVac, a conjugate vaccine.
Bårnes GK; Kristiansen PA; Beyene D; Workalemahu B; Fissiha P; Merdekios B; Bohlin J; Préziosi MP; Aseffa A; Caugant DA
BMC Infect Dis; 2016 Nov; 16(1):639. PubMed ID: 27814682
[TBL] [Abstract][Full Text] [Related]
16. The threat of meningococcal disease during the Hajj and Umrah mass gatherings: A comprehensive review.
Yezli S
Travel Med Infect Dis; 2018; 24():51-58. PubMed ID: 29751133
[TBL] [Abstract][Full Text] [Related]
17. Serogroup W-135 meningococcal disease during the Hajj, 2000.
Lingappa JR; Al-Rabeah AM; Hajjeh R; Mustafa T; Fatani A; Al-Bassam T; Badukhan A; Turkistani A; Makki S; Al-Hamdan N; Al-Jeffri M; Al Mazrou Y; Perkins BA; Popovic T; Mayer LW; Rosenstein NE
Emerg Infect Dis; 2003 Jun; 9(6):665-71. PubMed ID: 12781005
[TBL] [Abstract][Full Text] [Related]
18. The prevalence, serogroup distribution and risk factors of meningococcal carriage in adolescents and young adults in Turkey.
Tekin RT; Dinleyici EC; Ceyhan M; Karbuz A; Salman N; Sutçu M; Kurugol Z; Balliel Y; Celik M; Hacimustafaoglu M; Kuyucu N; Kondolot M; Sensoy G; Metin O; Kara SS; Dinleyici M; Kılıç O; Bayhan C; Gurbuz V; Aycan E; Memedova A; Karli A; Bozlu G; Celebi S
Hum Vaccin Immunother; 2017 May; 13(5):1182-1189. PubMed ID: 28140784
[TBL] [Abstract][Full Text] [Related]
19. Absence of Neisseria meningitidis from throat swabs of Kuwaiti pilgrims after returning from the Hajj.
Husain EH; Dashti AA; Electricwala QY; Abdulsamad AM; Al-Sayegh S
Med Princ Pract; 2010; 19(4):321-3. PubMed ID: 20516711
[TBL] [Abstract][Full Text] [Related]
20. Meningococcal serogroup A, C, W, and Y serum bactericidal antibody profiles in Hajj pilgrims.
Memish ZA; Yezli S; Almasri M; Assiri A; Turkestani A; Findlow H; Bai X; Borrow R
Int J Infect Dis; 2014 Nov; 28():171-5. PubMed ID: 25307887
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
